title: Angiotensin II induces EMMPRIN expression in THP-1 macrophages via the NF-kappaB pathway.
abstract: BACKGROUND
  Recent studies on atherosclerosis showed that an inducer of MMPs, EMMPRIN, is highly expressed in human atheromas. This suggested the important role of EMMPRIN in the stability of atherosclerotic plaques. Angiotensin II, one of the main functional peptides in the renin-angiotensin system, is involved in the advancement of atherosclerosis. We evaluated the effect of angiotensin II on EMMPRIN expression in THP-1 macrophages, and postulated the potential mechanisms underlying its effects.
  
  
  RESULTS
  We established THP-1 macrophages using PMA. The effect of angII on EMMPRIN expression in THP-1 macrophages was then investigated. Results from analyses of RT-PCR and western blotting showed that angII could upregulate EMMPRIN expression. This was mediated via the AT1R, but not the AT2R. The NF-kappaB inhibitor PDTC and P65 RNAi treatment could suppress the effect of angII on EMMPRIN, suggesting the involvement of the NF-kappaB pathway. A gelatin zymography assay showed that MMP-9 activity was related to EMMPRIN expression.
  
  
  CONCLUSIONS
  AngII upregulates the expression of EMMPRIN. NF-kappaB is the critical factor involved in the upregulation of EMMPRIN induced by angII.
authors.affiliation: Department of Cardiology, Kunming General Hospital of Chengdu Military Area, Yunnan 650032, China. doctorlxyang@163.com
authors.forename: Li-xia
authors.initials: LX
authors.lastname: Yang
authors.forename: Hong
authors.initials: H
authors.lastname: Liu
authors.forename: Rui-wei
authors.initials: RW
authors.lastname: Guo
authors.forename: Jinshan
authors.initials: J
authors.lastname: Ye
authors.forename: Xian-mei
authors.initials: XM
authors.lastname: Wang
authors.forename: Feng
authors.initials: F
authors.lastname: Qi
authors.forename: Chuan-ming
authors.initials: CM
authors.lastname: Guo
authors.forename: Xing
authors.initials: X
authors.lastname: Liang
mesh_terms: D000804:Angiotensin II / Q000494:pharmacology*; D051926:Basigin / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D008264:Macrophages / Q000187:drug effects* / Q000378:metabolism; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism; D016328:NF-kappa B / Q000378:metabolism*; D014407:Tumor Cells, Cultured; D015854:Up-Regulation / Q000187:drug effects
chemical_list: C497886:BSG protein, human; D016328:NF-kappa B; D000804:Angiotensin II; D051926:Basigin; D020780:Matrix Metalloproteinase 9